[1]
Edward L. Trimble, National Cancer Institute, Center for Global Health, Bethesda, MD;
Ali A. Chisti, Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI;
Jane A. Craycroft, Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA;
Kalina Duncan, National Cancer Institute, Center for Global Health, Bethesda, MD;
Manaswi Gupta, Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge,
MA;
Daniel Gutierrez, Global Oncology, Boston, MA;
Ilyana Rosenberg, Global Oncology, Boston, MA;
Nour Sharara, Global Oncology, Boston, MA;
Sudha Sivaram, National Cancer Institute, Center for Global Health, Bethesda, MD;
Hillary M. Topazian, National Cancer Institute, Center for Global Heatlh, Bethesda, MD;
Jing Jing Wang, Global Oncology, Boston, MA;
Makeda J. Williams, National Cancer Institute, Center for Global Health, Bethesda, MD;
Franklin W. Huang, Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA;
Ami S. Bhatt, Global Oncology, Boston, MA, and Stanford University, Stanford, CA.